What is MDLive?
Founded in 2009 and headquartered in Miramar, Florida, MDLive operates as a comprehensive telehealth platform. The company provides a robust digital interface for patients to access urgent care, primary care, mental health support, and dermatology services via phone or video. By bridging the gap between patients and clinicians, MDLive has established itself as a vital link in the healthcare delivery chain, particularly as the industry shifts toward decentralized, patient-centric care models. Its market position is defined by its integration into the broader health system, allowing for seamless coordination of care and improved patient outcomes through digital innovation.
How much funding has MDLive raised?
MDLive has raised a total of $271.6M across 5 funding rounds:
Private Equity
$23.6M
Series B
$50M
Private Equity
$50M
Other Financing Round
$123M
Debt
$25M
Private Equity (2014): $23.6M with participation from Sentara Healthcare, Heritage Group, Sutter Health, and Kayne Anderson Capital Advisors, L.P.
Series B (2015): $50M, investors not publicly disclosed
Private Equity (2018): $50M supported by Health Velocity Capital
Other Financing Round (2020): $123M featuring Cigna
Debt (2020): $25M, investors not publicly disclosed
Key Investors in MDLive
Cigna
The Cigna Group is a global health company committed to improving health and vitality through innovative solutions and strategic partnerships in healthcare services.
Health Velocity Capital
Health Velocity Capital is an investment firm that focuses exclusively on innovative healthcare software and services businesses to foster a more affordable and sustainable future.
Sentara Healthcare
Sentara Healthcare is a not-for-profit integrated healthcare system that operates a wide network of hospitals, outpatient facilities, and medical services.
What's next for MDLive?
With a history of major enterprise-level funding, MDLive is well-positioned to further expand its service offerings and technological capabilities. The strategic focus moving forward will likely involve deepening its integration with existing health systems and enhancing its AI-driven diagnostic tools to maintain a competitive edge in the crowded telehealth market. As the company continues to leverage its capital reserves, it is expected to prioritize market penetration and the diversification of its virtual care portfolio, ensuring that it remains at the forefront of the digital health transformation.
See full MDLive company page
